Intrinsic Value of S&P & Nasdaq Contact Us

Valneva SE VALN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.33
+201%

Valneva SE (VALN) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

The consensus price target is $18.33 (low: $14.00, high: $26.00), representing an upside of 201% from the current price $6.09.

Analysts estimate Earnings Per Share (EPS) of $-0.07 and revenue of $0.19B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.17 vs est $-0.07 (missed -161.5%). 2025: actual $-1.32 vs est $-1.08 (missed -21.8%). Analyst accuracy: 60%.

VALN Stock — 12-Month Price Forecast

$18.33
▲ +200.99% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for Valneva SE, the average price target is $18.33, with a high forecast of $26.00, and a low forecast of $14.00.
The average price target represents a +200.99% change from the last price of $6.09.
Highest Price Target
$26.00
Average Price Target
$18.33
Lowest Price Target
$14.00

VALN Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to Valneva SE in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — VALN

60%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual –$0.17 vs Est –$0.07 ▼ 61.8% off
2025 Actual –$1.32 vs Est –$1.08 ▼ 17.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — VALN

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.170B vs Est $0.186B ▼ 9.7% off
2025 Actual $0.175B vs Est $0.168B ▲ 3.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message